Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

p53-dependent autophagic degradation of TET2 modulates cancer therapeutic resistance

2 Nov 2018

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autophagy in Disease and Therapy
Share to Epigenetics and DNA Methylation
Share to RNA modifications and cancer

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 30390073
DOI: 10.1038/s41388-018-0524-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

p53-dependent autophagic degradation of TET2 modulates cancer therapeutic resistancePMID 30390073Read ↗

p53-mediated autophagic regulation: A prospective strategy for cancer therapySemantic proximity Read ↗

Complex Interplay between DNA Damage and Autophagy in Disease and TherapySemantic proximity Read ↗

Autophagy mediated immune response regulation and drug resistance in cancerSemantic proximity Read ↗

Triangular Relationship between p53, Autophagy, and Chemotherapy ResistanceSemantic proximity Read ↗

Tetherin Suppresses Type I Interferon Signaling by Targeting MAVS for NDP52-Mediated Selective Autophagic Degradation in Human CellsSemantic proximity Read ↗

A SIRT2-Selective Inhibitor Promotes c-Myc Oncoprotein Degradation and Exhibits Broad Anticancer ActivitySemantic proximity Read ↗

Pro-survival autophagy and cancer cell resistance to therapySemantic proximity Read ↗

Strategies for therapeutic targeting of the p53 pathway in cancer.Semantic proximity Read ↗

Small molecules that targeting p53 Y220C protein: mechanisms, structures, and clinical advances in anti-tumor therapySemantic proximity Read ↗

Mitophagy in the mechanisms of treatment resistance in solid tumorsSemantic proximity Read ↗

P53-regulated autophagy and its impact on drug resistance and cell fateSemantic proximity Read ↗

New Insights into Therapy-Induced Progression of CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.